7 September 2023
EUROCELL PLC
(the "Company")
Director/PDMR Shareholding
Eurocell plc (the "Company") announces that, on 5 September 2023, a director purchased shares in the Company.
The notification set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1. | Details of PDMR / person closely associated with them ("PCA") | |||||||
| a) | Name | Derek Mapp | ||||||
| 2. | Reason for the notification | |||||||
| a) | Position / status | Non-executive Director (Chair of the Board) | ||||||
| b) | Initial notification / amendment | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Eurocell plc | ||||||
| b) | Legal Entity Identifier | 213800RH62IQ7S9OFQ55 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument | Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | ||||||
| b) | Nature of the transaction | Purchase of Ordinary shares | ||||||
| c) | Price(s) and volume(s) |
* Acquired via a Small Self-Administered Pension Scheme | ||||||
| d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total
|
100,000 Ordinary Shares
£1.097 per share
£109,700 | ||||||
| e) | Date of the transaction | 5 September 2023 | ||||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||||
For further information:
Eurocell plc 01773 842 100
Paul Walker
Group Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
